Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 802 results for "alexion pharmaceuticals"

Piper Jaffray Reaffirms Buy Rating for Alexion Pharmaceuticals, Inc. (ALXN)
American Banking News - Earnings

Alexion Pharmaceuticals (ALXN) Overweight Rating Reaffirmed at...

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)s stock had its overweight rating reissued by investment analysts at Morgan Stanley in a report released on Wednesday. In other Alexion Pharmaceuticals news, EVP John B. Moriarty sold 918 shares of the ... SleekMoney, 8 hours ago
Piper Jaffray Reaffirms Buy Rating for Alexion Pharmaceuticals, Inc. (ALXN) American Banking News - Earnings, 2 days ago

28 images for alexion pharmaceuticals

American Banking News, 2 days ago, 2 days ago
Share Market Updates, 6 days ago
Share Market Updates, 2 days ago
Jutia Group, 3 weeks ago, 1 week ago
ASMAG, 1 week ago
ASMAG, 1 week ago
Share Market Updates, 2 weeks ago
Case Western Reserve University Observer, 2 weeks ago

Land swap helping pave way for Alexion Pharmaceuticals expansion in Smithfield [The Providence Journal, R.I.]

June 29--As the global drug manufacturer Alexion Pharmaceuticals , Inc., prepares to more than double the size of its manufacturing facility in Smithfield, the company sought and won help from the Rhode Island Commerce Corporation for a land swap. ...
 Bloomberg19 hours ago

Alexion Pharmaceuticals Achieves #55 Analyst Rank, Surpassing PPG Industries

 Forbes.com1 day ago PPG : Alexion Pharmaceuticals Achieves #55 Analyst Rank, Surpassing PPG Industries  4 Traders6 hours ago

Biotech: Buy the Brexit Blowup?

June 24, 2016 at 13:53 PM EDT Biotech: Buy the Brexit Blowup? With biotech stocks like Alexion Pharmaceuticals ( ALXN ), Biogen ( BIIB ), Amgen ( AMGN ), Celgene ( CELG ) and Gilead Sciences ( GILD ) getting pounded following Britain's ...
 Marketplace5 days ago Alexion Pharmaceuticals is Now Oversold (ALXN)  Forbes.com1 week ago Alexion Pharmaceuticals: Time to Buy?  BioSpace3 weeks ago

Here's Why Shares of Biogen and Alexion Tanked On Tuesday

Shares of Biogen ( BIIB) and Alexion Pharmaceuticals ( ALXN) took a hit Tuesday after their promising new products failed clinical trials. Biogen's experimental drug aimed at treating multiple sclerosis failed a mid-staged trial, prompted investors ...
 TheStreet.com3 weeks ago Here's What Biogen Inc MS Drug Failure Means for the Company  Bidness Etc2 weeks ago BIOGEN : MS Drug Fails Study Goals; Shares Drop 13% -- WSJ  4 Traders3 weeks ago BIOGEN : Shares Down as Multiple Sclerosis Therapy Misses Study Goals -- Update  4 Traders3 weeks ago

Alexion Closed Down 10%; Piper Says 'Buy On Weakness'

Traders and investors in Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN ) sold shares Tuesday following news from the company topline results from a REGAIN study did not hit statistical significance. While most analysts responded to the price decline ...
 Benzinga.com3 weeks ago
Hargreaves Lansdown

Stocks Not Having A Good Day: Catalent, Alexion Pharmaceuticals, DryShips, More

U.S stocks have edged higher on Tuesday following a rise in oil prices and Fed Chairwoman Janet Yellen's speech on Monday, in which she maintained an optimistic tone about the overall economic situation,despite the recent jobs report. However, ...
 InsiderMonkey.com3 weeks ago US close: Stocks end mostly higher as oil prices jump  BullBearings3 weeks ago 4 Stocks Moving In Monday's After-Hours Session  Benzinga.com3 weeks ago

Barclays Cuts Alexion Pharmaceuticals Target From $180 To $165

Barclays cut the estimates and price target of Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN ) after its phase 3 data for Soliris in myasthenia gravis (gMG) missed statistical significance on the primary endpoint. The brokerage has conservatively ...
 Benzinga.com3 weeks ago
Motley Fool

Why Alexion Pharmacetuicals Inc. Is Dropping Today

Image source: . What: Shareholders of rare-disease-focused Alexion Pharmaceuticals ( NASDAQ:ALXN ) are having a rough day. The stock is down more than 11% as of 12:30 a.m. EDT after the company released top-line results from a phase 3 clinical ...
 Motley Fool3 weeks ago
Libya News Today

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Alexion Pharmaceuticals, Inc. (ALXN)

NEW YORK , June 8, 2016 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Alexion Pharmaceuticals, Inc. ("Alexion" or "the Company") ( NASDAQ: ...
 International Business Times3 weeks ago Alexion drug misses goal in late-stage trial  Yahoo! Finance3 weeks ago SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alexion Pharmaceuticals, Inc. - ALXN  Barchart3 weeks ago UPDATE: Alexion shares fall after drug study fails to reach main goal  TD Ameritrade3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - alexion pharmaceuticals
Get updated on latest news & your favorite topics right in your inbox!
More     Less